Boston Therapeutics Reports Financial Results and Corporate Update for the Second Quarter and Six Months Ended June 30, 2013

MANCHESTER, NH -- (Marketwired) -- 08/09/13 -- Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the…

Continue Reading

Boston Therapeutics Launches SUGARDOWN(R) Publicity Campaign

Product Awareness Campaign to Target Selected Markets

Continue Reading

Boston Therapeutics Is Quoted as BTHE on the OTC Bulletin Board

MANCHESTER, NH -- (Marketwire) -- 03/22/12 -- (OTCBB: BTHE), a developer of diabetes therapeutics, is pleased…

Continue Reading